The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy
Open accessAbstract
Cholesterol/sphingolipid-rich membrane domains, known as lipid rafts or membrane rafts, play a critical role in the compartmentalization of signaling pathways. Physical segregation of proteins in lipid rafts may modulate the accessibility of proteins to regulatory or effector molecules. Thus, lipid rafts serve as sorting platforms and hubs for signal transduction proteins. Cancer cells contain higher levels of intracellular cholesterol and lipid rafts than their normal non-tumorigenic counterparts. Many signal transduction processes involved in cancer development (insulin-like growth factor system and phosphatidylinositol 3-kinase-AKT) and metastasis [cluster of differentiation (CD)44] are dependent on or modulated by lipid rafts. Additional proteins playing an important role in several malignant cancers (e.g., transmembrane glycoprotein mucin 1) are also being detected in association with lipid rafts, suggesting a major role of lipid rafts in tumor progression. Conversely, lipid rafts also serve as scaffolds for the recruitment and clustering of Fas/CD95 death receptors and downstream signaling molecules leading to cell death-promoting raft platforms. The partition of death receptors and downstream signaling molecules in aggregated lipid rafts has led to the formation of the so-called cluster of apoptotic signaling molecule-enriched rafts, or CASMER, which leads to apoptosis amplification and can be pharmacologically modulated. These death-promoting rafts can be viewed as a linchpin from which apoptotic signals are launched. In this review, we discuss the involvement of lipid rafts in major signaling processes in cancer cells, including cell survival, cell death, and metastasis, and we consider the potential of lipid raft modulation as a promising target in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tai, Y., Podar, K., Catley, L. P., Tseng, Y., Akiyama, M., Shringarpure, R., Burger, R., Hideshima, T., Chauhan, D., Mitsiades, N., et al. (2003) · PubMed · Cited by 219
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757 · cited 2×
“In addition to the above processes, cholesterol is a major regulator of lipid organization, being responsible for the close packing of acyl chains of phospholipids, promoting phase separation, and stabilizing the formation of cholesterol- and sphingolipid-rich membrane microdomains known as lipid rafts or membrane raf…”
BackgroundLipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Srimaroeng, C., Cecile, J. P., Walden, R., & Pritchard, J. B. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350077 · Cited by 2,989
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,721
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,184
The mystery of membrane organization: composition, regulation and roles of lipid rafts
Sezgin, E., Levental, I., Mayor, S., & Eggeling, C. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.16 · Cited by 2,124
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Estrogen Carcinogenesis in Breast Cancer
Yager, J. D., & Davidson, N. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050776 · Cited by 1,862
Rafts defined: a report on the Keystone symposium on lipid rafts and cell function
Pike, L. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.e600002-jlr200 · Cited by 1,500
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Role of cholesterol and lipid organization in disease
Maxfield, F. R., & Tabas, I. (2005) · Nature · doi:10.1038/nature04399 · Cited by 1,293
Targeting the PI3K-Akt pathway in human cancer
Luo, J., Manning, B. D., & Cantley, L. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00248-4 · Cited by 1,290
Ten years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177
A Role for Lipid Shells in Targeting Proteins to Caveolae, Rafts, and Other Lipid Domains
Anderson, R. G. W., & Jacobson, K. (2002) · Science · doi:10.1126/science.1068886 · Cited by 1,125
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,082
Mechanisms of receptor tyrosine kinase activation in cancer
Du, Z., & Lovly, C. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0782-4 · Cited by 1,066
Membrane Organization and Lipid Rafts
Simons, K., & Sampaio, J. L. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004697 · Cited by 1,064
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Takaishi, S., Okumura, T., Tu, S., Wang, S. S. W., Shibata, W., Vigneshwaran, R., Gordon, S. A. K., Shimada, Y., & Wang, T. C. (2009) · Stem Cells · doi:10.1002/stem.30 · Cited by 1,039
Targeting the PI3K pathway in cancer: are we making headway?
Janku, F., Yap, T. A., & Meric-Bernstam, F. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.28 · Cited by 1,033
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
An Induced Proximity Model for Caspase-8 Activation
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2926 · Cited by 1,023
Cholesterol, lipid rafts, and disease
Simons, K., & Ehehalt, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16390 · Cited by 989
Estrogen receptor signaling mechanisms
(2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.01.001 · Cited by 988
Cholesterol, lipid rafts, and disease
Simons, K., & Ehehalt, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216390 · Cited by 916
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · Cancer Communications · doi:10.1186/s40880-018-0301-4 · Cited by 850
LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
Zelcer, N., Hong, C., Boyadjian, R., & Tontonoz, P. (2009) · Science · doi:10.1126/science.1168974 · Cited by 848
Senbanjo, L. T., & Chellaiah, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00018 · Cited by 842
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Nelson, E. R., Wardell, S. E., Jasper, J. S., Park, S., Suchindran, S., Howe, M. K., Carver, N. J., Pillai, R. V., Sullivan, P. M., Sondhi, V., et al. (2013) · Science · doi:10.1126/science.1241908 · Cited by 839
Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting
(2005) · Advances in Cancer Research · doi:10.1016/s0065-230x(05)94002-5 · Cited by 823
Phase transitions and fluidity characteristics of lipids and cell membranes
Chapman, D. (1975) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500001797 · Cited by 799
AKT as a Therapeutic Target for Cancer
Song, M., Bode, A. M., Dong, Z., & Lee, M.-H. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2738 · Cited by 782
Coming together to define membrane contact sites
Scorrano, L., De Matteis, M. A., Emr, S., Giordano, F., Hajnóczky, G., Kornmann, B., Lackner, L. L., Levine, T. P., Pellegrini, L., Reinisch, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09253-3 · Cited by 730
Statin Use and Reduced Cancer-Related Mortality
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1214827 · Cited by 720
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
The Role of Cholesterol in Cancer
Kuzu, O. F., Noory, M. A., & Robertson, G. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2613 · Cited by 708
Lipid rafts: heterogeneity on the high seas
PIKE, L. J. (2004) · Biochemical Journal · doi:10.1042/bj20031672 · Cited by 703
PI3K/Akt: getting it right matters
Franke, T. F. (2008) · Oncogene · doi:10.1038/onc.2008.313 · Cited by 695
Life and death by death receptors
Guicciardi, M. E., & Gores, G. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-111005 · Cited by 690
CD95 Signaling via Ceramide-rich Membrane Rafts
Grassme, H., Jekle, A., Riehle, A., Schwarz, H., Berger, J., Sandhoff, K., Kolesnick, R., & Gulbins, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101207200 · Cited by 636
Structure and function of the type 1 insulin-like growth factor receptor
Adams, T. E., Epa, V. C., Garrett, T. P. J., & Ward*, C. W. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000744 · Cited by 630
Roles of lipid rafts in membrane transport
Ikonen, E. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00238-6 · Cited by 629
Increased lipogenesis in cancer cells: new players, novel targets
Swinnen, J. V., Brusselmans, K., & Verhoeven, G. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232894.28674.30 · Cited by 610
Obesity and Prostate Cancer: Weighing the Evidence
Allott, E. H., Masko, E. M., & Freedland, S. J. (2013) · European Urology · doi:10.1016/j.eururo.2012.11.013 · Cited by 601
Zhuang, L., Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519935 · Cited by 567 · cited 1×
“Elevation of circulating cholesterol in SCID mice promoted tumor growth and increased Akt phosphorylation as well as the cholesterol content and the extent of protein tyrosine phosphorylation in lipid rafts isolated from LNCaP (androgen-sensitive human prostate adenocarcinoma cells) xenograft tumors, and reduced apopt…”
BackgroundWhat's so special about cholesterol?
Mouritsen, O. G., & Zuckermann, M. J. (2004) · Lipids · doi:10.1007/s11745-004-1336-x · Cited by 537
Li, Y. C., Park, M. J., Ye, S.-K., Kim, C.-W., & Kim, Y.-N. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050959 · Cited by 536
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
Allard, J. B., & Duan, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00117 · Cited by 515
Letter: The consultants' contract.
Plumley, P. F. (1974) · PubMed · Cited by 460
Quantitative imaging of membrane lipid order in cells and organisms
Owen, D. M., Rentero, C., Magenau, A., Abu-Siniyeh, A., & Gaus, K. (2012) · Nature Protocols · doi:10.1038/nprot.2011.419 · Cited by 458
Raturi, A., & Simmen, T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.04.013 · Cited by 447
Palmitoylation-dependent Estrogen Receptor α Membrane Localization: Regulation by 17β-Estradiol
Acconcia, F., Ascenzi, P., Bocedi, A., Spisni, E., Tomasi, V., Trentalance, A., Visca, P., & Marino, M. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0547 · Cited by 438
Baek, A. E., Yu, Y.-R. A., He, S., Wardell, S. E., Chang, C.-Y., Kwon, S., Pillai, R. V., McDowell, H. B., Thompson, J. W., Dubois, L. G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00910-z · Cited by 427
Cholesterol, the central lipid of mammalian cells
Maxfield, F. R., & van Meer, G. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.05.004 · Cited by 414
TNF ligands and receptors – a matter of life and death
MacEwan, D. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704549 · Cited by 391
Ceramide Enables Fas to Cap and Kill
Cremesti, A., Paris, F., Grassmé, H., Holler, N., Tschopp, J., Fuks, Z., Gulbins, E., & Kolesnick, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101866200 · Cited by 380
Lipids as Targeting Signals: Lipid Rafts and Intracellular Trafficking
Helms, J. B., & Zurzolo, C. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.0181.x · Cited by 376
The role of the insulin-like growth factor-1 system in breast cancer
Christopoulos, P. F., Msaouel, P., & Koutsilieris, M. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0291-7 · Cited by 376
Lipid Droplets in Cancer: Guardians of Fat in a Stressful World
Petan, T., Jarc, E., & Jusović, M. (2018) · Molecules · doi:10.3390/molecules23081941 · Cited by 368
Membrane Oligomerization and Cleavage Activates the Caspase-8 (FLICE/MACHα1) Death Signal
Martin, D. A., Siegel, R. M., Zheng, L., & Lenardo, M. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4345 · Cited by 358
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Wu, Q., Ishikawa, T., Sirianni, R., Tang, H., McDonald, J. G., Yuhanna, I. S., Thompson, B., Girard, L., Mineo, C., Brekken, R. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.006 · Cited by 358
Neutrophil Degranulation, Plasticity, and Cancer Metastasis
Mollinedo, F. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.01.006 · Cited by 353
Self-citationDickens, L. S., Boyd, R. S., Jukes-Jones, R., Hughes, M. A., Robinson, G. L., Fairall, L., Schwabe, J. W. R., Cain, K., & MacFarlane, M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.004 · Cited by 349
Lipid rafts in immune signalling: current progress and future perspective
Varshney, P., Yadav, V., & Saini, N. (2016) · Immunology · doi:10.1111/imm.12617 · Cited by 332
Mechanism and biological significance of CD44 cleavage
Nagano, O., & Saya, H. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03179.x · Cited by 325
Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation
Lasserre, R., Guo, X.-J., Conchonaud, F., Hamon, Y., Hawchar, O., Bernard, A.-M., Soudja, S. M., Lenne, P.-F., Rigneault, H., Olive, D., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.103 · Cited by 316
Lipid rafts as major platforms for signaling regulation in cancer
Mollinedo, F., & Gajate, C. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.10.003 · Cited by 308
Self-citationCisplatin-Induced CD95 Redistribution into Membrane Lipid Rafts of HT29 Human Colon Cancer Cells
Lacour, S., Hammann, A., Grazide, S., Lagadic-Gossmann, D., Athias, A., Sergent, O., Laurent, G., Gambert, P., Solary, E., & Dimanche-Boitrel, M.-T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2787 · Cited by 306
Cholesterol and prostate cancer
Pelton, K., Freeman, M. R., & Solomon, K. R. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.006 · Cited by 303
Receptor Tyrosine Kinase-Targeted Cancer Therapy
Yamaoka, T., Kusumoto, S., Ando, K., Ohba, M., & Ohmori, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113491 · Cited by 297
Treatment of Estrogen Receptor-Positive Breast Cancer
Lumachi, F., Brunello, A., Maruzzo, M., Basso, U., & Basso, S. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713804999303 · Cited by 291
Delmas, D., Rébé, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304896200 · Cited by 291
Li, H., Stampfer, M. J., Hollis, J. B. W., Mucci, L. A., Gaziano, J. M., Hunter, D., Giovannucci, E. L., & Ma, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040103 · Cited by 290
Lipid rafts: signaling and sorting platforms of cells and their roles in cancer
Staubach, S., & Hanisch, F.-G. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.2 · Cited by 284
Gajate, C., & Mollinedo, F. (2007) · Blood · doi:10.1182/blood-2006-04-016824 · Cited by 280
Self-citationConstitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Rudelius, M., Pittaluga, S., Nishizuka, S., Pham, T. H.-T., Fend, F., Jaffe, E. S., Quintanilla-Martinez, L., & Raffeld, M. (2006) · Blood · doi:10.1182/blood-2006-04-015586 · Cited by 277
Gajate, C., & Mollinedo, F. (2001) · Blood · doi:10.1182/blood.v98.13.3860 · Cited by 276
Self-citationCeramide-mediated clustering is required for CD95-DISC formation
Grassmé, H., Cremesti, A., Kolesnick, R., & Gulbins, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206540 · Cited by 271
Estrogen Receptors: New Directions in the New Millennium
Hewitt, S. C., & Korach, K. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00087 · Cited by 240
Targeting tumor cell metabolism with statins
Clendening, J. W., & Penn, L. Z. (2012) · Oncogene · doi:10.1038/onc.2012.6 · Cited by 239
Death-effector Filaments: Novel Cytoplasmic Structures that Recruit Caspases and Trigger Apoptosis
Siegel, R. M., Martin, D. A., Zheng, L., Ng, S. Y., Bertin, J., Cohen, J., & Lenardo, M. J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1243 · Cited by 234
Covalent lipid modifications of proteins
Resh, M. D. (2013) · Current Biology · doi:10.1016/j.cub.2013.04.024 · Cited by 231
Isoform-specific Localization of Voltage-gated K+Channels to Distinct Lipid Raft Populations
Martens, J. R., Sakamoto, N., Sullivan, S. A., Grobaski, T. D., & Tamkun, M. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009948200 · Cited by 230
The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
Raccosta, L., Fontana, R., Maggioni, D., Lanterna, C., Villablanca, E. J., Paniccia, A., Musumeci, A., Chiricozzi, E., Trincavelli, M. L., Daniele, S., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130440 · Cited by 230
Sphingolipids and lipid rafts: Novel concepts and methods of analysis
Bieberich, E. (2018) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2018.08.003 · Cited by 229
Identification of Human Pancreatic Cancer Stem Cells
Li, C., Lee, C. J., & Simeone, D. M. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-280-9_10 · Cited by 227
Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review)
Shi, X., Wang, J., Lei, Y., Cong, C., Tan, D., & Zhou, X. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10121 · Cited by 226
Mollinedo, F., Fernández-Luna, J. L., Gajate, C., Martín-Martín, B., Benito, A., MARTÍNEZ-DALMAU, R., & Modolell, M. (1997) · PubMed · Cited by 221
Self-citationHueber, A., Bernard, A., Hérincs, Z., Couzinet, A., & He, H. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf022 · Cited by 221
The death effector domain protein family: regulators of cellular homeostasis
Tibbetts, M. D., Zheng, L., & Lenardo, M. J. (2003) · Nature Immunology · doi:10.1038/ni0503-404 · Cited by 218
Parlato, S., Giammarioli, A. M., Logozzi, M., Lozupone, F., Matarrese, P., Luciani, F., Falchi, M., Malorni, W., & Fais, S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5123 · Cited by 217
PLASMA LIPIDS AND MORTALITY: A SOURCE OF ERROR
Rose, G., & Shipley, M. J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92775-0 · Cited by 217
Gajate, C., del Canto-Jañez, E., Acuña, A. U., Amat-Guerri, F., Geijo, E., Santos-Beneit, A. M., Veldman, R. J., & Mollinedo, F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040213 · Cited by 217
Self-citationPI(3,4,5)P 3 Engagement Restricts Akt Activity to Cellular Membranes
Ebner, M., Lučić, I., Leonard, T. A., & Yudushkin, I. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.028 · Cited by 217
Oberst, A., Pop, C., Tremblay, A. G., Blais, V., Denault, J.-B., Salvesen, G. S., & Green, D. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095083 · Cited by 214
Delmas, D., Rébé, C., Micheau, O., Athias, A., Gambert, P., Grazide, S., Laurent, G., Latruffe, N., & Solary, E. (2004) · Oncogene · doi:10.1038/sj.onc.1208086 · Cited by 212
Cholesterol lowering: role in cancer prevention and treatment
Murai, T. (2015) · Biological Chemistry · doi:10.1515/hsz-2014-0194 · Cited by 207
Pike, L. J., Han, X., & Gross, R. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503805200 · Cited by 206
Pommier, A. J. C., Alves, G., Viennois, E., Bernard, S., Communal, Y., Sion, B., Marceau, G., Damon, C., Mouzat, K., Caira, F., et al. (2010) · Oncogene · doi:10.1038/onc.2010.30 · Cited by 206
Sugahara, K. N., Murai, T., Nishinakamura, H., Kawashima, H., Saya, H., & Miyasaka, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300347200 · Cited by 204
Lipid transport by TMEM24 at ER–plasma membrane contacts regulates pulsatile insulin secretion
Lees, J. A., Messa, M., Sun, E. W., Wheeler, H., Torta, F., Wenk, M. R., De Camilli, P., & Reinisch, K. M. (2017) · Science · doi:10.1126/science.aah6171 · Cited by 204
Schleich, K., Warnken, U., Fricker, N., Öztürk, S., Richter, P., Kammerer, K., Schnölzer, M., Krammer, P. H., & Lavrik, I. N. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.006 · Cited by 198
The Role of Oxysterols in Human Cancer
Kloudova, A., Guengerich, F. P., & Soucek, P. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.03.002 · Cited by 197
Statin drugs to reduce breast cancer recurrence and mortality
Beckwitt, C. H., Brufsky, A., Oltvai, Z. N., & Wells, A. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1066-z · Cited by 197
PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains
Gao, X., Lowry, P. R., Zhou, X., Depry, C., Wei, Z., Wong, G. W., & Zhang, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019386108 · Cited by 195
The oxysterol receptor LXR inhibits proliferation of human breast cancer cells
Vedin, L.-L., Lewandowski, S. A., Parini, P., Gustafsson, J.-Å., & Steffensen, K. R. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp029 · Cited by 194
Palmitoylation is required for efficient Fas cell death signaling
Chakrabandhu, K., Hérincs, Z., Huault, S., Dost, B., Peng, L., Conchonaud, F., Marguet, D., He, H., & Hueber, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601456 · Cited by 190
Lipid rafts–protein association and the regulation of protein activity
Lucero, H. A., & Robbins, P. W. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.03.020 · Cited by 189
Cholesterol and breast cancer pathophysiology
Nelson, E. R., Chang, C.-Y., & McDonnell, D. P. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.10.001 · Cited by 187
MUC1 and metastatic cancer: Expression, function and therapeutic targeting
Horm, T. M., & Schroeder, J. A. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.23131 · Cited by 187
Gajate, C., & Mollinedo, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411781200 · Cited by 184
Self-citationPivotal Role of the Lipid Raft SK3–Orai1 Complex in Human Cancer Cell Migration and Bone Metastases
Chantôme, A., Potier-Cartereau, M., Clarysse, L., Fromont, G., Marionneau-Lambot, S., Guéguinou, M., Pagès, J.-C., Collin, C., Oullier, T., Girault, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4572 · Cited by 184
Chimento, A., Casaburi, I., Avena, P., Trotta, F., De Luca, A., Rago, V., Pezzi, V., & Sirianni, R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00807 · Cited by 183
Murai, T., Maruyama, Y., Mio, K., Nishiyama, H., Suga, M., & Sato, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.184010 · Cited by 179
Psahoulia, F. H., Drosopoulos, K. G., Doubravska, L., Andera, L., & Pintzas, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0001 · Cited by 179
Iams, W. T., & Lovly, C. M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2518 · Cited by 179
Gajate, C., & Mollinedo, F. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337225 · Cited by 177
Self-citationStatin Use After Colorectal Cancer Diagnosis and Survival: A Population-Based Cohort Study
Cardwell, C. R., Hicks, B. M., Hughes, C., & Murray, L. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.4569 · Cited by 177
Staubach, S., Razawi, H., & Hanisch, F. (2009) · PROTEOMICS · doi:10.1002/pmic.200800793 · Cited by 175
Sprynski, A. C., Hose, D., Caillot, L., Réme, T., Shaughnessy, J. D., Barlogie, B., Seckinger, A., Moreaux, J., Hundemer, M., Jourdan, M., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170464 · Cited by 173
White, A. B., Givogri, M. I., Lopez-Rosas, A., Cao, H., van Breemen, R., Thinakaran, G., & Bongarzone, E. R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5597-08.2009 · Cited by 171
Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae
Vainio, S., Heino, S., Månsson, J., Fredman, P., Kuismanen, E., Vaarala, O., & Ikonen, E. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf010 · Cited by 170
Garofalo, T., Matarrese, P., Manganelli, V., Marconi, M., Tinari, A., Gambardella, L., Faggioni, A., Misasi, R., Sorice, M., & Malorni, W. (2016) · Autophagy · doi:10.1080/15548627.2016.1160971 · Cited by 170
Plasma membrane organization and function: moving past lipid rafts
Kraft, M. L. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-03-0165 · Cited by 168
Hypertension, serum lipids and cancer risk: A review of epidemiological evidence
Radišauskas, R., Kuzmickienė, I., Milinavičienė, E., & Everatt, R. (2016) · Medicina · doi:10.1016/j.medici.2016.03.002 · Cited by 168
Low-Density Lipoprotein Cholesterol and the Risk of Cancer: A Mendelian Randomization Study
Benn, M., Tybjærg-Hansen, A., Stender, S., Frikke-Schmidt, R., & Nordestgaard, B. G. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr008 · Cited by 167
Endoplasmic reticulum-plasma membrane contact sites integrate sterol and phospholipid regulation
Quon, E., Sere, Y. Y., Chauhan, N., Johansen, J., Sullivan, D. P., Dittman, J. S., Rice, W. J., Chan, R. B., Di Paolo, G., Beh, C. T., et al. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2003864 · Cited by 167
Spatiotemporal Analysis of Differential Akt Regulation in Plasma Membrane Microdomains
Gao, X., & Zhang, J. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-05-0449 · Cited by 165
Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis
Miyaji, M., Jin, Z.-X., Yamaoka, S., Amakawa, R., Fukuhara, S., Sato, S. B., Kobayashi, T., Domae, N., Mimori, T., Bloom, E. T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041685 · Cited by 164
van der Luit, A. H., Budde, M., Ruurs, P., Verheij, M., & van Blitterswijk, W. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203176200 · Cited by 164
Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective
Krycer, J. R., & Brown, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.01.002 · Cited by 162
Fas/CD95 death receptor and lipid rafts: New targets for apoptosis-directed cancer therapy
MOLLINEDO, F., & GAJATE, C. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.04.002 · Cited by 161
Self-citationLigand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects
Wei, W., Schwaid, A. G., Wang, X., Wang, X., Chen, S., Chu, Q., Saghatelian, A., & Wan, Y. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.010 · Cited by 161
Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment
Liu, M., Tolg, C., & Turley, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00947 · Cited by 161
Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors
Okamoto, I., Tsuiki, H., Kenyon, L. C., Godwin, A. K., Emlet, D. R., Holgado-Madruga, M., Lanham, I. S., Joynes, C. J., Vo, K. T., Guha, A., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64863-8 · Cited by 160
Feig, C., Tchikov, V., Schütze, S., & Peter, M. E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601460 · Cited by 160
Moltedo, O., Remondelli, P., & Amodio, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00172 · Cited by 159
Engagement of CD44 Promotes Rac Activation and CD44 Cleavage during Tumor Cell Migration
Murai, T., Miyazaki, Y., Nishinakamura, H., Sugahara, K. N., Miyauchi, T., Sako, Y., Yanagida, T., & Miyasaka, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307356200 · Cited by 156
Guéguinou, M., Harnois, T., Crottès, D., Uguen, A., Déliot, N., Gambade, A., Chantôme, A., Haelters, J. P., Jaffrès, P. A., Jourdan, M. L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8786 · Cited by 154
The Role of Lipid Rafts in Cancer Cell Adhesion and Migration
Murai, T. (2011) · International Journal of Cell Biology · doi:10.1155/2012/763283 · Cited by 150
Janich, P., & Corbeil, D. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.065 · Cited by 149
Chapuis, N., Tamburini, J., Cornillet‐Lefèbvre, P., Gillot, L., Bardet, V., Willems, L., Park, S., Green, A. S., Ifrah, N., Dreyfus, F., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.010785 · Cited by 147
Huo, H., Guo, X., Hong, S., Jiang, M., Liu, X., & Liao, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211785200 · Cited by 145
Cholesterol and breast cancer development
Danilo, C., & Frank, P. G. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.009 · Cited by 145
Gajate, C., Fonteríz, R. I., Cabaner, C., Alvarez-Noves, G., Alvarez-Rodríguez, Y., Modolell, M., & Mollinedo, F. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000301)85:5<674::aid-ijc13>3.0.co;2-z · Cited by 144
Self-citationCholesteryl esters in malignancy
Tosi, M. R., & Tugnoli, V. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.003 · Cited by 144
Membrane-Associated Estrogen Receptor Signaling Pathways in Human Cancers
Pietras, R. J., & Márquez‐Garbán, D. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1373 · Cited by 144
Surmacz, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206772 · Cited by 143
Barnett‐Norris, J., Lynch, D. L., & Reggio, P. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.040 · Cited by 143
The current evidence on statin use and prostate cancer prevention: are we there yet?
Alfaqih, M. A., Allott, E. H., Hamilton, R. J., Freeman, M. R., & Freedland, S. J. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.199 · Cited by 141
The role of cholesterol in the association of endoplasmic reticulum membranes with mitochondria
Fujimoto, M., Hayashi, T., & Su, T.-P. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.022 · Cited by 140
Hyaluronan-CD44 axis orchestrates cancer stem cell functions
Skandalis, S. S., Karalis, T. T., Chatzopoulos, A., & Karamanos, N. K. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109377 · Cited by 138
Feedback Regulation of Cholesterol Uptake by the LXR–IDOL–LDLR Axis
Zhang, L., Reue, K., Fong, L. G., Young, S. G., & Tontonoz, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.250571 · Cited by 137
Cholesterol Sensitivity of Endogenous and Myristoylated Akt
Adam, R. M., Mukhopadhyay, N. K., Kim, J., Vizio, D. D., Cinar, B., Boucher, K., Solomon, K. R., & Freeman, M. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0288 · Cited by 134
Orian‐Rousseau, V., & Sleeman, J. P. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00009-5 · Cited by 131
Rosa, P. L., Pesiri, V., Leclercq, G., Marino, M., & Acconcia, F. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1208 · Cited by 130
Shafique, K., McLoone, P., Qureshi, K. N., Leung, H. Y., Hart, C., & Morrison, D. S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-25 · Cited by 130
Huang, Q. B., Shen, H., Shui, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0077 · Cited by 130
Mollinedo, F., Gajate, C., Martín‐Santamaría, S., & Gago, F. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043363703 · Cited by 129
Self-citationMitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
Annunziata, I., Sano, R., & d’Azzo, A. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0025-4 · Cited by 127
Lipid raft heterogeneity: an enigma
Mishra, S., & Joshi, P. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04720.x · Cited by 126
Sorice, M., Parolini, I., Sansolini, T., Garofalo, T., Dolo, V., Sargiacomo, M., Tai, T., Peschle, C., Torrisi, M. R., & Pavan, A. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37221-7 · Cited by 125
A Western-Type Diet Accelerates Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer
Llaverı́as, G., Danilo, C., Wang, Y., Witkiewicz, A. K., Daumer, K. M., Lisanti, M. P., & Frank, P. G. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100568 · Cited by 124
Göbel, A., Breining, D., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1322-x · Cited by 124
Raghu, H., Sodadasu, P. K., Malla, R. R., Gondi, C. S., Estes, N. C., & Rao, J. S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-647 · Cited by 122
Lipid raft-targeted therapy in multiple myeloma
Mollinedo, F., de la Iglesia-Vicente, J., Gajate, C., de Mendoza, A. E., Villa-Pulgarín, J. A., Campanero, M. A., & Blanco‐Prieto, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.131 · Cited by 120
Self-citationRevisiting the IGF-1R as a breast cancer target
Ekyalongo, R. C., & Yee, D. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0017-y · Cited by 114
Differences in antitumor effects of various statins on human pancreatic cancer
Gbelcová, H., Leníček, M., Zelenka, J., Knejzlík, Z., Dvořáková, G., Zadinová, M., POUCKOVA, P., Kudla, M., Baláž, P., Ruml, T., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23242 · Cited by 113
Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer
Márquez, D. C., Chen, H., Curran, E. M., Welshons, W. V., & Pietras, R. J. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.020 · Cited by 112
Insulin-like growth factor type I biology and targeting in malignant gliomas
Trojan, J., Cloix, J., Ardourel, M., Chatel, M., & Anthony, D. D. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.021 · Cited by 112
Thankamony, S. P., & Knudson, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601530200 · Cited by 110
Gajate, C., González‐Camacho, F., & Mollinedo, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005044 · Cited by 108
Self-citationPalmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling
Rossin, A., Derouet, M. F., Abdel‐Sater, F., & Hueber, A. (2008) · Biochemical Journal · doi:10.1042/bj20081212 · Cited by 107
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study
Jamnagerwalla, J., Howard, L. E., Allott, E. H., Vidal, A. C., Moreira, D. M., Castro‐Santamaria, R., Andriole, G. L., Freeman, M. R., & Freedland, S. J. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-017-0030-9 · Cited by 106
The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
Pollak, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0998 · Cited by 105
Fitzgerald, T. L., & McCubrey, J. A. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.05.001 · Cited by 104
Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma
Reis-Sobreiro, M., Roué, G., Moros, A., Gajate, C., de la Iglesia-Vicente, J., Colomer, D., & Mollinedo, F. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.15 · Cited by 103
Self-citationLipid raft connection between extrinsic and intrinsic apoptotic pathways
Gajate, C., González‐Camacho, F., & Mollinedo, F. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.147 · Cited by 103
Self-citationOpposing Actions of Endocannabinoids on Cholangiocarcinoma Growth
DeMorrow, S., Glaser, S. S., Francis, H., Venter, J. K., Vaculin, B. T., Vaculin, S., & Alpini, G. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608238200 · Cited by 100
Calay, D., Vind-Kezunovic, D., Frankart, A., Lambert, S., Poumay, Y., & Gniadecki, R. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.415 · Cited by 99
Endoplasmic Reticulum Stress in the Proapoptotic Action of Edelfosine in Solid Tumor Cells
Nieto-Miguel, T., Fonteríz, R. I., Vay, L., Gajate, C., López-Hernández, S., & Mollinedo, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0278 · Cited by 97
Self-citationLipid Rafts in Neurodegeneration and Neuroprotection
Sonnino, S., Aureli, M., Grassi, S., Mauri, L., Prioni, S., & Prinetti, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8614-4 · Cited by 95
Mollinedo, F., de la Iglesia-Vicente, J., Gajate, C., de Mendoza, A. E., Villa-Pulgarín, J. A., de Frías, M., Roué, G., Gil, J., Colomer, D., Campanero, M. Á., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2456 · Cited by 94
Self-citationFunction of insulin‑like growth factor 1 receptor in cancer resistance to chemotherapy (Review)
Yuan, J., Yin, Z., Tao, K., Wang, G., & Gao, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.7276 · Cited by 92
Restricted Localization of the TNF Receptor CD120a to Lipid Rafts: A Novel Role for the Death Domain
Cottin, V., Doan, J. E. S., & Riches, D. W. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4095 · Cited by 91
Yang, Z.-S., Qin, W., Chen, Y., Yuan, B., Song, X.-L., Wang, B., Shen, F., Fu, J., & Wang, H.-Y. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.038 · Cited by 91
Yi, J., Balagopalan, L., Nguyen, T. T. M., McIntire, K. M., & Samelson, L. E. (2019) · Nature Communications · doi:10.1038/s41467-018-08064-2 · Cited by 91
Moretti, S., Procopio, A. D., Lazzarini, R., Rippo, M. R., Testa, R., Marra, M., Tamagnone, L., & Catalano, A. (2007) · Blood · doi:10.1182/blood-2007-06-096529 · Cited by 88
Reis-Sobreiro, M., Gajate, C., & Mollinedo, F. (2009) · Oncogene · doi:10.1038/onc.2009.183 · Cited by 88
Self-citationCholesterol esters as growth regulators of lymphocytic leukaemia cells
Mulas, M. F., Abete, C., Pulisci, D., Pani, A., Massidda, B., Dessı̀, S., & Mandas, A. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00758.x · Cited by 87
Slaughter, N., Laux, I., Tu, X., Whitelegge, J. P., Zhu, X., Effros, R. B., Bickel, P. E., & Nel, A. E. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00097-4 · Cited by 87
Cited by
Lipid composition of the cancer cell membrane
Szlasa, W., Zendran, I., Zalesińska, A., Tarek, M., & Kulbacka, J. (2020) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-020-09846-4 · Cited by 435
Cholesterol metabolism: New functions and therapeutic approaches in cancer
Xu, H., Zhou, S., Tang, Q., Xia, H., & Bi, F. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188394 · Cited by 365
Obesity, Diabetes, and Increased Cancer Progression
Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 302
Duranti, C., Iorio, J., Manganelli, V., Bagni, G., Colasurdo, R., Lottini, T., Martinelli, M., Capitani, C., Boso, G., D’Alessandro, F. N., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02321-2 · Cited by 8
“Hence, LRs are emerging as pivotal membrane hubs to modulate intracellular pathways [13 – 16] that are particularly relevant in cancer [17], and may represent putative targets for anticancer drug development [18].”
Metadata
- Authors
- Mollinedo, F., & Gajate, C.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 61
- Issue
- 5
- Pages
- 611-635
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W3003322304
- Cited by
- 279
- References
- 299
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.